It is not possible to generalize how long a patient with a lymphoma can survive; the exact survival period varies depending on the type of pathology and stage of the lymphoma. According to pathological classification, lymphoma can be divided into two categories: Hodgkin’s lymphoma and non-Hodgkin’s lymphoma. Clinically, “five-year survival rate” is commonly used to assess the survival rate of patients. 1. Hodgkin’s lymphoma has a better prognosis. Early stage Hodgkin’s lymphoma has a better prognosis, such as stage Ⅰ and stage Ⅱ, the 5-year survival rate is above 90%. The survival rate of advanced Hodgkin’s lymphoma needs to be speculated based on the International Prognostic Score. 2. Non-Hodgkin’s lymphoma, a heterogeneous group of lymphomas, currently usually adopts the International Prognostic Index (IPI) as the prognostic stratification evaluation, and classifies the prognosis into 4 categories: low-risk, low-intermediate-risk, medium-intermediate-risk, and high-risk. an IPI number of 0-1 belongs to the low-risk category, with a 5-year survival rate of 73%; IPI number of 2 belongs to the low-intermediate-risk category, with a 5-year survival rate of 50%; IPI number of 3 belongs to the medium-intermediate-risk category, with a 5-year survival rate The 5-year survival rate is 43%; IPI number 4-5 is high risk and the 5-year survival rate is 26%. Patients can improve the prognosis and reduce the adverse effects of the disease through early detection, early diagnosis and early treatment. It is recommended that patients actively undergo regular treatment.